Propanc Biopharma : Material Agreement : vimarsana.com

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549



FORM 8-K



CURRENT REPORT


...

Related Keywords

United States , Delaware , Washington , Camberwell , Victoria , Australia , James Nathanielsz , Propanc Biopharma Inc , Securities Exchange , General Instruction , Securities Act , Exchange Act , Securities Exchange Act , Material Definitive , Propanc Biopharma , June Investor , June Note , Common Stock , Conversion Shares , July Investor , Letter Agreement , Purchase Agreement , Loan Agreement , Current Report , Direct Financial Obligation , Off Balance Sheet Arrangement , Executive Officer , Chief Financial , Markets ,